ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ARAY Accuray Incorporated

2.19
0.01 (0.46%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Accuray Incorporated NASDAQ:ARAY NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.01 0.46% 2.19 2.15 2.34 2.23 2.16 2.20 344,340 23:00:01

Accuray To Report Fiscal 2017 Second Quarter Financial Results On January 31, 2017

17/01/2017 12:30pm

PR Newswire (US)


Accuray (NASDAQ:ARAY)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Accuray Charts.

SUNNYVALE, Calif., Jan. 17, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its fiscal second quarter ended December 31, 2016 on Tuesday, January 31, 2017 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT/4:30 p.m. ET on the same day.

The conference call dial-in numbers are 855-867-4103 (USA) or 262-912-4764 (International).  In addition, a dial up replay of the conference call will be available approximately one hour after the call's conclusion for one week.  The replay number is 855-859-2056 (USA), or 404-537-3406 (International), Conference ID: 52778138.

A live webcast of the call will also be available from the Investor Relations section of the Company's website at www.accuray.com/investors.  A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the third quarter of fiscal 2017, ending March 31, 2017.

About Accuray

Accuray Incorporated (NASDAQ: ARAY) is a radiation oncology company that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives.  The Company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments.  For more information, please visit www.accuray.com

Contacts:




Investors:  

Brian Moore, EVC Group, 310-770-0389, bmoore@evcgroup.com


Doug Sherk, EVC Group, 415-652-9100, dsherk@evcgroup.com



Media: 

Beth Kaplan


Public Relations Director, Accuray


408-789-4426


bkaplan@accuray.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/accuray-to-report-fiscal-2017-second-quarter-financial-results-on-january-31-2017-300391608.html

SOURCE Accuray Incorporated

Copyright 2017 PR Newswire

1 Year Accuray Chart

1 Year Accuray Chart

1 Month Accuray Chart

1 Month Accuray Chart

Your Recent History

Delayed Upgrade Clock